Skip to content

Exelixis EXEL Total Assets

Total Assets at other companies

Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Pfizer logo
PfizerPFE
$207.62B-0.2%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$647.86M+68.8%
Incyte logo
IncyteINCY
$7.34B+27.7%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$3.45B+22.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$1.37B+55.5%

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's total assets?
Exelixis (EXEL) reported total assets of $2.59B in Q1 2026.
How has Exelixis's total assets changed year-over-year?
Exelixis's total assets decreased by 8.6% year-over-year, from $2.84B to $2.59B.
What is the long-term trend for Exelixis's total assets?
Over 5 years (2020 to 2025), Exelixis's total assets has grown at a 5.9% compound annual growth rate (CAGR), from $2.14B to $2.84B.
What does total assets mean?
The total value of everything the company owns.
How do you interpret total assets?
Growth in total assets generally indicates business expansion, though it must be balanced against the efficiency of asset utilization.
How does total assets compare across companies?
Standard metric for company size; peers are compared based on asset base relative to revenue and market capitalization.